Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2016 | Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway | Liu W.-L.; HUNG-CHIH YANG ; Hsu C.-S; Wang C.-C; Wang T.-S; JIA-HORNG KAO ; DING-SHINN CHEN | Proceedings of the National Academy of Sciences of the United States of America | 9 | 9 | |
2013 | Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | CHEN-HUA LIU ; Huang, Chung-Feng; CHUN-JEN LIU ; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; HUNG-BIN TSAI ; MENG-KUN TSAI ; Chen, Shih-I; JOU-WEI LIN ; Yang, Sheng-Shun; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; Chuang, Wan-Long; Yu, Ming-Lung; JIA-HORNG KAO | Annals of internal medicine | 85 | 77 | |
2020 | Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing | Yang Y.-C.; Chen Y.-H; JIA-HORNG KAO ; Ching C; Liu I.-J; Wang C.-C; Tsai C.-H; Wu F.-Y; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; HUNG-CHIH YANG | Molecular Therapy - Nucleic Acids | 59 | 52 | |
2014 | Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: Molecular mechanisms and clinical significance | HUNG-CHIH YANG ; JIA-HORNG KAO | Emerging Microbes and Infections | 102 | 104 | |
2018 | The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA | HUNG-CHIH YANG ; PEI-JER CHEN | Virus Research | 41 | 33 | |
2023 | Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection | TUNG-HUNG SU ; SHANG-CHIN HUANG ; CHI-LING CHEN ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; YAO-MING WU ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2008 | Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription | Zhou Y; Shen L; HUNG-CHIH YANG ; Siliciano R.F. | Journal of Virology | 16 | 18 | |
2008 | Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation | Chase A.J; HUNG-CHIH YANG ; Zhang H; Blankson J.N; Siliciano R.F. | Journal of Virology | 108 | 105 | |
2014 | A primary CD4+ T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence | Kim M; Hosmane N.N; Bullen C.K; Capoferri A; HUNG-CHIH YANG ; Siliciano J.D; Siliciano R.F. | Nature Protocols | 42 | 41 | |
2011 | Primary cell models of HIV latency | HUNG-CHIH YANG | Current Opinion in HIV and AIDS | 17 | 18 | |
2019 | Profile and value of FIB-4 in patients with dual chronic hepatitis C and B | CHUN-JEN LIU ; TAI-CHUNG TSENG ; Yang W.-T; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 10 | 9 | |
2022 | Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma | Wang, Sung-Yin; TUNG-HUNG SU ; BANG-BIN CHEN ; CHUN-JEN LIU ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 4 | 4 | |
2018 | Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection | HUNG-CHIH YANG ; Tsou H.-H; Pei S.-N; Chang C.-S; Chen J.-H; MING YAO ; Lin S.-J; Lin J; Yuan Q; Xia N; Liu T.-W; PEI-JER CHEN ; ANN-LII CHENG ; CHIUN HSU ; Taiwan Cooperative Oncology Group | Journal of Hepatology | 69 | 58 | |
2019 | Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus | HUNG-CHIH YANG ; JIA-HORNG KAO | Gut | 4 | 2 | |
2015 | Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection | Song L.-W.; Liu P.-G; CHUN-JEN LIU ; Zhang T.-Y; Cheng X.-D; Wu H.-L; HUNG-CHIH YANG ; Hao X.-K; Yuan Q; Zhang J; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Clinical Microbiology and Infection | 98 | 86 | |
2018 | Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 25 | 24 | |
2018 | Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHUN-MING HONG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | PLoS ONE | 11 | 10 | |
2020 | Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data | CHUN-MING HONG ; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; PEI-JER CHEN ; Chen Y.-W; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of Microbiology, Immunology and Infection | 17 | 18 | |
2022 | Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas | Yang, Yu-Chan; HUNG-CHIH YANG | Viruses | 14 | 11 | |
2020 | Relationship between serum gamma-glutamyl transferase level and colorectal adenoma | TZU-CHAN HONG ; HUNG-CHIH YANG ; CHI-LING CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU ; Chen M.-J; Wang H.-Y; Kuo Y.-C; Yu L.-Y; Hu K.-C. | PLoS ONE | 4 | 2 | |